-
CompareEGMTM-MV Microvascular Endothelial Growth Medium SingleQuotsTM KitCatalog #: CC-4143
This product has been discontinued. The suggested alternative is EGMTM-2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTTM (Catalog # CC-3202) and/or its components.
Sales unit: each -
CompareEGM™-MV Microvascular Endothelial Cell Growth Medium BulletKit™Catalog #: CC-3125
This product has been discontinued. The suggested alternative is EGMTM-2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTM (Cat. # CC-3202) and/or its components.
Sales unit: kit -
CompareEGM™-2 Endothelial Cell Growth Medium-2 BulletKit™Catalog #: CC-3162
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 SingleQuotsTM Supplements (CC-4176) required for growth of Endothelial Cells. Available for immediate shipment.
Sales unit: kit -
CompareEGM™ MV Microvascular Endothelial Cell Growth Medium BulletKit™ (6 Pack)Catalog #: CC-3125/6
This product has been discontinued. The suggested alternative is EGMTM-2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTTM (Catalog # CC-3202) and/or its components.
Sales unit: kit -
CompareHuman Peripheral Blood CD14+ Monocytes, Cryopreserved, Negative Selection, 50 millionCatalog #: 4W-400ACryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, negative selection, containing ≥ 50 million cellsSales unit: each
-
CompareNHLF – Human Lung FibroblastsCatalog #: CC-2512
Cryopreserved ampule of Normal Human Lung Fibroblasts (NHLF) containing ≥ 500,000 cells
Do you need a modified version of this cell product, such as different vialing sizes, or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each -
ComparePyroWave™ XM Fluorescence ReaderCatalog #: 25-345S
The PyroWaveTM XM Fluorescence Reader brings a new generation in fluorescence technology to users of the PyroGeneTM Recombinant Factor C Endotoxin Detection Assay. This fluorescence microplate reader is optimized for Lonza’s PyroGeneTM Assay, bringing new and improved technology to the laboratory.
Sales unit: each -
CompareD-SAEC-COPD – Diseased Small Airway Epithelial Cells – COPDCatalog #: CC-2934
D-SAEC-COPD, Small Airway Epithelial Cells from donors with COPD
Sales unit: Ampule -
CompareHIAEC – Human Iliac Artery Endothelial CellsCatalog #: CC-2545HIAEC, Iliac Artery Endothelial CellsSales unit: each
-
CompareD-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells – AsthmaCatalog #: 00194911D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells from donors having AsthmaSales unit: Ampule
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay -
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.